Literature DB >> 28620713

Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma.

Meha Kabra1, Wei Zhang2, Sonika Rathi1, Anil K Mandal3,4, Sirisha Senthil3,4, Goutham Pyatla1, Muralidhar Ramappa5, Seema Banerjee6, Konegari Shekhar6, Srinivas Marmamula6, Asha L Mettla6, Inderjeet Kaur1, Rohit C Khanna6, Hemant Khanna2, Subhabrata Chakrabarti7.   

Abstract

Primary congenital glaucoma (PCG) is a severe autosomal recessive ocular disorder associated with considerable clinical and genetic heterogeneity. Recently, rare heterozygous alleles in the angiopoietin receptor-encoding gene TEK were implicated in PCG. We undertook this study to ascertain the second mutant allele in a large cohort (n = 337) of autosomal recessive PCG cases that carried heterozygous TEK mutations. Our investigations revealed 12 rare heterozygous missense mutations in TEK by targeted sequencing. Interestingly, four of these TEK mutations (p.E103D, p.I148T, p.Q214P, and p.G743A) co-occurred with three heterozygous mutations in another major PCG gene CYP1B1 (p.A115P, p.E229K, and p.R368H) in five families. The parents of these probands harbored either of the heterozygous TEK or CYP1B1 alleles and were asymptomatic, indicating a potential digenic mode of inheritance. Furthermore, we ascertained the interactions of TEK and CYP1B1 by co-transfection and pull-down assays in HEK293 cells. Ligand responsiveness of the wild-type and mutant TEK proteins was assessed in HUVECs using immunofluorescence analysis. We observed that recombinant TEK and CYP1B1 proteins interact with each other, while the disease-associated allelic combinations of TEK (p.E103D)::CYP1B1 (p.A115P), TEK (p.Q214P)::CYP1B1 (p.E229K), and TEK (p.I148T)::CYP1B1 (p.R368H) exhibit perturbed interaction. The mutations also diminished the ability of TEK to respond to ligand stimulation, indicating perturbed TEK signaling. Overall, our data suggest that interaction of TEK and CYP1B1 contributes to PCG pathogenesis and argue that TEK-CYP1B1 may perform overlapping as well as distinct functions in manifesting the disease etiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28620713      PMCID: PMC5953556          DOI: 10.1007/s00439-017-1823-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Prevalence of CYP1B1 mutations in Australian patients with primary congenital glaucoma.

Authors:  D P Dimasi; A W Hewitt; T Straga; J Pater; J R MacKinnon; J E Elder; T Casey; D A Mackey; J E Craig
Journal:  Clin Genet       Date:  2007-09       Impact factor: 4.438

2.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

3.  Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.

Authors:  William A Barton; Dorothea Tzvetkova-Robev; Edward P Miranda; Momchil V Kolev; Kanagalaghatta R Rajashankar; Juha P Himanen; Dimitar B Nikolov
Journal:  Nat Struct Mol Biol       Date:  2006-05-28       Impact factor: 15.369

Review 4.  Overview of Cytochrome P450 1B1 gene mutations in patients with primary congenital glaucoma.

Authors:  Ni Li; Yong Zhou; Liang Du; Maoling Wei; Xiaoming Chen
Journal:  Exp Eye Res       Date:  2011-08-16       Impact factor: 3.467

Review 5.  Molecular genetics in glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2011-08-18       Impact factor: 3.467

6.  Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.

Authors:  Andrea L Vincent; Gail Billingsley; Yvonne Buys; Alex V Levin; Megan Priston; Graham Trope; Donna Williams-Lyn; Elise Héon
Journal:  Am J Hum Genet       Date:  2002-01-03       Impact factor: 11.025

7.  Longitudinal Andhra Pradesh Eye Disease Study: rationale, study design and research methodology.

Authors:  Rohit C Khanna; Gudlavalleti Vs Murthy; Srinivas Marmamula; Asha Latha Mettla; Pyda Giridhar; Seema Banerjee; Konegari Shekhar; Subhabrata Chakrabarti; Clare Gilbert; Gullapalli N Rao
Journal:  Clin Exp Ophthalmol       Date:  2015-11-08       Impact factor: 4.207

8.  Null mutations in LTBP2 cause primary congenital glaucoma.

Authors:  Manir Ali; Martin McKibbin; Adam Booth; David A Parry; Payal Jain; S Amer Riazuddin; J Fielding Hejtmancik; Shaheen N Khan; Sabika Firasat; Mike Shires; David F Gilmour; Katherine Towns; Anna-Louise Murphy; Dimitar Azmanov; Ivailo Tournev; Sylvia Cherninkova; Hussain Jafri; Yasmin Raashid; Carmel Toomes; Jamie Craig; David A Mackey; Luba Kalaydjieva; Sheikh Riazuddin; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2009-04-09       Impact factor: 11.025

9.  A lymphatic defect causes ocular hypertension and glaucoma in mice.

Authors:  Benjamin R Thomson; Stefan Heinen; Marie Jeansson; Asish K Ghosh; Anees Fatima; Hoon-Ki Sung; Tuncer Onay; Hui Chen; Shinji Yamaguchi; Aris N Economides; Ann Flenniken; Nicholas W Gale; Young-Kwon Hong; Amani Fawzi; Xiaorong Liu; Tsutomu Kume; Susan E Quaggin
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

Review 10.  Primary infantile glaucoma (congenital glaucoma).

Authors:  V P deLuise; D R Anderson
Journal:  Surv Ophthalmol       Date:  1983 Jul-Aug       Impact factor: 6.048

View more
  13 in total

1.  Exome-based mutation screening in South African children with primary congenital glaucoma.

Authors:  Nadia Carstens; Saadiah Goolam; Michaella Hulley; Jean-Tristan Brandenburg; Michele Ramsay; Susan Eileen Isabella Williams
Journal:  Eye (Lond)       Date:  2022-01-29       Impact factor: 4.456

2.  Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension.

Authors:  Mitchell Brigell; Barbara Withers; Akshay Buch; Kevin G Peters
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

Review 3.  Ocular Ciliopathies: Genetic and Mechanistic Insights into Developing Therapies.

Authors:  Mahesh Shivanna; Manisha Anand; Subhabrata Chakrabarti; Hemant Khanna
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 4.  Research progress on human genes involved in the pathogenesis of glaucoma (Review).

Authors:  Hong-Wei Wang; Peng Sun; Yao Chen; Li-Ping Jiang; Hui-Ping Wu; Wen Zhang; Feng Gao
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

5.  First Results from the Prospective German Registry for Childhood Glaucoma: Phenotype-Genotype Association.

Authors:  Julia V Stingl; Stefan Diederich; Heidi Diel; Alexander K Schuster; Felix M Wagner; Panagiotis Chronopoulos; Fidan Aghayeva; Franz Grehn; Jennifer Winter; Susann Schweiger; Esther M Hoffmann
Journal:  J Clin Med       Date:  2021-12-21       Impact factor: 4.241

Review 6.  Cytochrome P450 1B1: role in health and disease and effect of nutrition on its expression.

Authors:  Bakht Ramin Shah; Wei Xu; Jan Mraz
Journal:  RSC Adv       Date:  2019-07-04       Impact factor: 4.036

7.  Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.

Authors:  Benjamin R Thomson; Isabel A Carota; Tomokazu Souma; Saily Soman; Dietmar Vestweber; Susan E Quaggin
Journal:  Elife       Date:  2019-10-17       Impact factor: 8.140

8.  Loss of PRSS56 function leads to ocular angle defects and increased susceptibility to high intraocular pressure.

Authors:  Cassandre Labelle-Dumais; Goutham Pyatla; Seyyedhassan Paylakhi; Nicholas G Tolman; Syed Hameed; Yusef Seymens; Eric Dang; Anil K Mandal; Sirisha Senthil; Rohit C Khanna; Meha Kabra; Inderjeet Kaur; Simon W M John; Subhabrata Chakrabarti; K Saidas Nair
Journal:  Dis Model Mech       Date:  2020-05-29       Impact factor: 5.758

9.  A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.

Authors:  Guorong Li; Astrid F Nottebaum; Mitchell Brigell; Iris D Navarro; Ute Ipe; Sarthak Mishra; Maria Gomez-Caraballo; Heather Schmitt; Brandi Soldo; Steve Pakola; Barbara Withers; Kevin G Peters; Dietmar Vestweber; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.925

10.  Screening and Functional Analysis of TEK Mutations in Chinese Children With Primary Congenital Glaucoma.

Authors:  Yunsheng Qiao; Yuhong Chen; Chen Tan; Xinghuai Sun; Xueli Chen; Junyi Chen
Journal:  Front Genet       Date:  2021-12-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.